Arbutus Biopharma Corporation
NASDAQ: ABUSWarminster, US · British Columbia, Canada corporation · 1 known investors
Biotech
Founders & leadership
AC
Andrew ChengDirector
EV
Eric VenkerDirector
WH
William H. CollierPresident and Chief Executive Officer
GP
Gaston PicchioChief Development Officer
MJ
Michael J. McElhaughChief Business Officer
FT
Frank TortiChairman
DB
Daniel BurgessDirector
DC
David C. HastingsChief Financial Officer
MJ
Michael J. SofiaChief Scientific Officer
JM
James MeyersDirector
EH
Elizabeth HowardExecutive Officer
TT
Tram TranDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew ChengDirector
- Eric VenkerDirector
- William H. CollierExecutive Officer, Director
- Gaston PicchioExecutive Officer
- Michael J. McElhaughExecutive Officer
- Frank TortiDirector
- Daniel BurgessDirector
- David C. HastingsExecutive Officer
- Michael J. SofiaExecutive Officer
- James MeyersDirector
- Elizabeth HowardExecutive Officer
- Tram TranDirector
- Richard C. HenriquesDirector
- Keith ManchesterDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Dec 2016
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.